Literature DB >> 429961

DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization.

B S Wilson, F Indiveri, M A Pellegrino, S Ferrone.   

Abstract

11 cultured human melanoma cell lines were tested for the expression of DR antigens by using specific allo- and xenoantisera in an indirect rosette microassay. Four of these melanoma cell lines expressed DR antigens, but in lower amounts than expressed on cultured human B-lymphoid cells. Rabbits injected with the DR-positive melanoma cells produced antibodies that were serologically and immunochemically reactive with B-cell-derived DR antigens. Immunochemical studies indicate that melanoma cell-derived DR antigens have a two-chain structure with 34,000 and 27,000 mol wt components. The melanoma cell-derived DR beta-chain at 27,000 mol wt is slightly smaller than that of the Victor cell DR beta-chain whose mol wt is 29,000.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429961      PMCID: PMC2184823          DOI: 10.1084/jem.149.3.658

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  Human DR (Ia-like) antigens: biological and molecular profile.

Authors:  S Ferrone; J P Allison; M A Pellegrino
Journal:  Contemp Top Mol Immunol       Date:  1978

2.  Purification and structural characterisation of human HLA-linked B-cell antigens.

Authors:  T A Springer; J F Kaufman; C Terhorst; J L Strominger
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

3.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

4.  Epidermal Langerhans cells express Ia antigens.

Authors:  L Klareskog; U Tjernlund; U Forsum; P A Peterson
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

5.  Murine Ia and human DR antigens: homology of amino-terminal sequences.

Authors:  J P Allison; L E Walker; W A Russell; M A Pellegrino; S Ferrone; R A Reisfeld; J A Frelinger; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera.

Authors:  B O Bergholtz; E Thorsby
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

7.  Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.

Authors:  S Ferrone; M A Pellegrino
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

8.  Cellular distrubtion, purification, and molecular nature of human Ia antigens.

Authors:  D Snary; C J Barnstable; W F Bodmer; P N Goodfellow; M J Crumpton
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation.

Authors:  R J Winchester; G D Ross; C I Jarowski; C Y Wang; J Halper; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

10.  Immunogenicity of human B cell antigens solubilized from cultured human lymphoid cells.

Authors:  S Ferrone; M A Pellegrino; R A Reisfeld
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

View more
  26 in total

1.  DNA content and MHC class II antigen expression in malignant melanoma: clinical course.

Authors:  J Zaloudik; M Moore; A K Ghosh; Z Mechl; A Rejthar
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

2.  HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.

Authors:  D Guerry; M A Alexander; M F Herlyn; L M Zehngebot; K F Mitchell; C M Zmijewski; E J Lusk
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

Review 3.  Comments on the isolation and enrichment of human Langerhans cells for use in immunological studies.

Authors:  M S Pollack; M A Goldenhersh; J Chin-Louie; B Safai
Journal:  Surv Immunol Res       Date:  1982

4.  Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens.

Authors:  P G Natali; O Segatto; S Ferrone; R Tosi; G Corte
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Changes in Ia-like antigen expression on malignant human cells.

Authors:  P G Natali; C De Martino; V Quaranta; A Bigotti; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis.

Authors:  L Jonasson; J Holm; O Skalli; G Gabbiani; G K Hansson
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.

Authors:  R V Lloyd; T L Johnson; M Blaivas; J C Sisson; B S Wilson
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

8.  Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.

Authors:  G K Hansson; L Jonasson; J Holm; L Claesson-Welsh
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

9.  Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies.

Authors:  J Brüggen; C Sorg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.

Authors:  M Maio; M Altomonte; R Tatake; R A Zeff; S Ferrone
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.